The SEC stayed the approval of a rule proposal submitted by Nasdaq.
4 reports, 3 independent
Updated Aug 18
Gone quiet
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The SEC stayed the approval of a rule proposal submitted by Nasdaq.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.SEC stayed the approval of a Nasdaq rule proposal.1 source
Nasdaq sought SEC approval to extend trading hours.1 source
Keep exploring
The entities involved
Related events
- IPO filings are subject to SEC oversight, involving the Nasdaq stock exchange and the SEC.
- Offering filed with SEC and declared effective for Southern Cross Acquisition II Corp., with IPO expected on Nasdaq Capital Market.
- Allient stock traded on NASDAQ and filed required disclosures with the SEC on August 18, 2026.
- BioLineRx Ltd. is utilizing the Nasdaq stock exchange for a registered direct offering, filing with the SEC.
- Investment is supporting a company's continued compliance with Nasdaq listing requirements.